Clausenamide is a chiral compound isolated from leaves of the traditional Chinese herb Clausena lansium (lour) Skeels. It has been shown that (-)
clausenamide, but not (+)
clausenamide, improved learning and memory in
amnesia animal models. However, the precise mechanism of
clausenamide's actions remains unknown. Here we used an electrophysiological approach to observe the effect of (-)
clausenamide on facilitating field excitatory postsynaptic potential (f-EPSP) in the CA1 area of hippocampal slices from rats. The results showed that (-)
clausenamide enhanced synaptic transmission at doses 0.1, 1 and 10 μM. The increase of f-EPSP induced by (-)
clausenamide was completely inhibited by preincubation with
nimodipine (L-
voltage-dependent calcium channel blocker, 10 μM), but there was no change when
nimodipine was added after (-)
clausenamide application. However,
ryanodine (
ryanodine receptors blocker, 100 μM) attenuated the slope of f-EPSP before or after (-)
clausenamide incubation. The data suggested that (-)
clausenamide promoted
calcium influx to trigger intracellular
calcium release which was responsible for potentiating synaptic transmission. Intracellular
calcium release induced by (-)
clausenamide promoted the activation of CaMKIIα at concentrations of 0.1, 1 and 10 μM, and pretreatment with
KN93 (CaMKIIα inhibitor, 10 μM) completely blocked the enhancement of synaptic transmission induced by (-)
clausenamide.
cAMP response element-binding protein (CREB) was activated by (-)
clausenamide and inhibited by
KN93 preincubation, but
H89 (
PKA inhibitor, 10 μM) had no effect, indicating that (-)
clausenamide facilitated synaptic transmission by a PKA-independent pathway. Collectively, (-)
clausenamide facilitated synaptic transmission by promoting
calcium influx to trigger intracellular
calcium release, subsequently activating CaMKIIα-CREB signal pathway.